Lonafarnib
Various Alimentary Tract and Metabolism Products
Sold as Zokinvy
- Drug class
- Various Alimentary Tract and Metabolism Products
- Availability
- See label
- Markets covered
- 2
- Products on record
- 4
Overview
Lonafarnib is an active pharmaceutical ingredient in the Various Alimentary Tract and Metabolism Products group (A16AX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 3 | April 24, 2026 |
| EU European Union | EMA | 1 | April 7, 2026 |
GBUnited Kingdom· MHRA
3 products
Uses
Zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of Hutchinson-Gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous LMNA mutation with progerin-like protein accumulation or a homozygous or compound heterozygous ZMPSTE24 mutation.
How to take
EUEuropean Union· EMA
1 product
Uses
Zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of Hutchinson-Gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous LMNA mutation with progerin-like protein accumulation or a homozygous or compound heterozygous ZMPSTE24 mutation.
How to take
Drug interactions
Known interactions involving Lonafarnib. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 380. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PLGB567090001 · revised June 16, 2025
- [2]European Medicines Agency · EMEA/H/C/005271 · revised April 7, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.